A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 31 December 2019 |
| Author/s |
author: James Spicer |
| Publication date | December 31, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |